Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons

被引:77
作者
Obata, Fumiko [1 ,2 ]
Tohyama, Koujiro [4 ]
Bonev, Adrian D. [3 ]
Kolling, Glynis L. [1 ,2 ]
Keepers, Tiffany R. [1 ,2 ]
Gross, Lisa K. [1 ,2 ]
Nelson, Mark T. [3 ]
Sato, Shigehiro [5 ]
Obrig, Tom G. [1 ,2 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Med Nephrol, Charlottesville, VA USA
[2] Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA
[3] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA
[4] Iwate Med Univ, Ctr Electron Microscopy & Bioimaging Res, Lab Nanoneuroanat, Morioka, Iwate 020, Japan
[5] Iwate Med Univ, Dept Microbiol, Morioka, Iwate 020, Japan
关键词
D O I
10.1086/591911
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Affinity-purified Shiga toxin (Stx) 2 given intraperitoneally to mice caused weight loss and hind-limb paralysis followed by death. Globotriaosylceramide (Gb3), the receptor for Stx2, was localized to neurons of the central nervous system (CNS) of normal mice. Gb3 was not found in astrocytes or endothelial cells of the CNS. In human cadaver CNS, we found Gb3 in neurons and endothelial cells. Mouse Gb3 localization was confirmed by immunoelectron microscopy. In Stx2-exposed mice, anti-Stx2-gold immunoreaction was positive in neurons. During paralysis, after Stx2 injection, multiple glial nuclei were observed surrounding motoneurons by electron microscopy. Also revealed was a lamellipodia-like process physically inhibiting the synaptic connection of motoneurons. Ca2+ imaging of cerebral astrocytic end-feet in Stx2-treated mouse brains suggested that the toxin increased neurotransmitter release from neurons. In this article, we propose that the neuron is a primary target of Stx2, affecting neuronal function and leading to paralysis.
引用
收藏
页码:1398 / 1406
页数:9
相关论文
共 48 条
[1]   Improved methods for ultracryotomy of CNS tissue for ultrastructural and immunogold analyses [J].
Akagi, Takumi ;
Ishida, Kinji ;
Hanasaka, Tomohito ;
Hayashi, Shuichiro ;
Watanabe, Masahiko ;
Hashikawa, Tsutomu ;
Tohyama, Koujiro .
JOURNAL OF NEUROSCIENCE METHODS, 2006, 153 (02) :276-282
[2]   CNS-MANIFESTATIONS OF THE HEMOLYTIC-UREMIC SYNDROME - RELATIONSHIP TO METABOLIC ALTERATIONS AND PROGNOSIS [J].
BALE, JF ;
BRASHER, C ;
SIEGLER, RL .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1980, 134 (09) :869-872
[3]   DISPLACEMENT OF SYNAPTIC TERMINALS FROM REGENERATING MOTONEURONS BY MICROGLIAL CELLS [J].
BLINZING.K ;
KREUTZBE.G .
ZEITSCHRIFT FUR ZELLFORSCHUNG UND MIKROSKOPISCHE ANATOMIE, 1968, 85 (02) :145-&
[4]  
BOS AP, 1985, HELV PAEDIATR ACTA, V40, P381
[5]  
CIMOLAI N, 1992, PEDIATRICS, V90, P616
[6]   Bacterial genotype and neurological complications of Escherichia coli O157:H7 associated haemolytic uraemic syndrome [J].
Cimolai, N ;
Carter, JE .
ACTA PAEDIATRICA, 1998, 87 (05) :593-594
[7]   SITE OF ACTION OF A VERO TOXIN (VT2) FROM ESCHERICHIA-COLI O157-H7 AND OF SHIGA TOXIN ON EUKARYOTIC RIBOSOMES - RNA N-GLYCOSIDASE ACTIVITY OF THE TOXINS [J].
ENDO, Y ;
TSURUGI, K ;
YUTSUDO, T ;
TAKEDA, Y ;
OGASAWARA, T ;
IGARASHI, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 171 (1-2) :45-50
[8]   Induction of apoptosis of human brain microvascular endothelial cells by Shiga toxin 1 [J].
Ergonul, Z ;
Hughes, AK ;
Kohan, DE .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (01) :154-158
[9]   Calcium dynamics in cortical astrocytes and arterioles during neurovascular coupling [J].
Filosa, JA ;
Bonev, AD ;
Nelson, MT .
CIRCULATION RESEARCH, 2004, 95 (10) :E73-E81
[10]   Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria:: A prospective study [J].
Gerber, A ;
Karch, H ;
Allerberger, F ;
Verweyen, HM ;
Zimmerhackl, LB .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (04) :493-500